OncoMed Pharmaceuticals Inc
OncoMed Pharmaceuticals Inc (OMED) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 524 transactions totaling $38.1M, demonstrating a bullish sentiment with $8.4M in net insider flow. The most recent transaction on Apr 23, 2019 involved a transaction of 80,500 shares valued at $0.
OMED Insider Activity Summary
Who Is Buying OMED Stock?
No significant insider buying has been recorded for OMED in the recent period.
Who Is Selling OMED Stock?
No significant insider selling has been recorded for OMED in the recent period.
Is OncoMed Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OMED is bullish with an Insider Alignment Score of 61/100 and a net flow of $8.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OMED Frequently Asked Questions
Understanding OMED Insider Activity
Insider trading at OncoMed Pharmaceuticals Inc (OMED) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading OMED stock, having executed 524 transactions in the past 90 days. The most active insider is Deepika Pakianathan (Executive), who has made 12 transactions totaling $8.0M.
Related Tools
Track OncoMed Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at OMED file new Form 4 transactions